VENUS REMEDIES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 318.6 INR | -1.04% |
|
+7.13% | -21.51% |
| Mar. 19 | Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs | MT |
| Mar. 08 | Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 51.57M | - | - | - | - | - | |
| 739B | ||||||
| 598B | ||||||
| 353B | ||||||
| 318B | ||||||
| 285B |
